Home
About THA
Affiliates
THA Board of Directors
Affiliates
Delaware THA
Florida THA
Illinois THA
Maryland THA
New Jersey THA
New York THA
Pennsylvania THA
Aftercare
DTHA – CANTER MidAtlantic and MidAtlantic Horse Rescue
ITHA – Galloping Out
MTHA – Beyond The Wire
NJTHA – Second Call
NYTHA – Take2
PTHA – Turning For Home
Thoroughbred Aftercare Alliance
Retired Racehorse Project
Horsemen Resources
Claiming Rules
Condition Books
Continuing Education
Entries
Horsemen’s Accounts
Industry Links
Layoff Report
Licensing
Mid-Atlantic Strategic Plan to Reduce Equine Fatalities
Overnights
Owner Concierge
Racetracks
Racing Commissions
Results
Rules and Regulations
Stall Applications
State Fact Books (JC)
Video Replays
Medication Information
Uniform Medication Overview
Controlled Therapeutic Substances List & Guidelines
Joint Injection Reporting Requirements
THA’s Position on Lasix
Medication Alerts
Multiple Medication Violation Penalty System
National Uniform Medication Progress
Out-of-Competition Testing
Racing Medication and Testing Consortium
ARCI Uniform Classification of Foreign Substances
State Medication Regulations
ARCI Penalty Guidelines
News
Thoroughbred Horsemen's Association
Search for:
Home
About THA
Affiliates
THA Board of Directors
Affiliates
Delaware THA
Florida THA
Illinois THA
Maryland THA
New Jersey THA
New York THA
Pennsylvania THA
Aftercare
DTHA – CANTER MidAtlantic and MidAtlantic Horse Rescue
ITHA – Galloping Out
MTHA – Beyond The Wire
NJTHA – Second Call
NYTHA – Take2
PTHA – Turning For Home
Thoroughbred Aftercare Alliance
Retired Racehorse Project
Horsemen Resources
Claiming Rules
Condition Books
Continuing Education
Entries
Horsemen’s Accounts
Industry Links
Layoff Report
Licensing
Mid-Atlantic Strategic Plan to Reduce Equine Fatalities
Overnights
Owner Concierge
Racetracks
Racing Commissions
Results
Rules and Regulations
Stall Applications
State Fact Books (JC)
Video Replays
Medication Information
Uniform Medication Overview
Controlled Therapeutic Substances List & Guidelines
Joint Injection Reporting Requirements
THA’s Position on Lasix
Medication Alerts
Multiple Medication Violation Penalty System
National Uniform Medication Progress
Out-of-Competition Testing
Racing Medication and Testing Consortium
ARCI Uniform Classification of Foreign Substances
State Medication Regulations
ARCI Penalty Guidelines
News
Tag Archives: Horseracing Integrity and Safety Authority
HISA quarterly metrics report reflects decrease in racing-related fatalities
HISA rescinds memorandum regarding the shipping of Louisiana-based racehorses
HISA defers action on provisional suspensions for metformin pending further study
HISA, HIWU release metrics reports for 2023 activities
HISA to fund three scientific studies on use of Lasix in Thoroughbreds
ARCI releases assessment report examining HISA programs
HISA releases report on fatalities at Laurel Park
HISA submits proposed changes to Anti-Doping and Medication Control Program rules
HISA projects racetrack assessments at $77.52 million for 2024
HISA introduces national concussion protocol for jockeys
Proposed changes to HISA Racetrack Safety Program rules submitted
HISA, Guild outline jockey wellness initiatives during symposium
HISA announces immediate policy changes on provisional suspensions
HISA adjusts regulations on intra-articular injections, provides guidance
HISA announces members of advisory committee to oversee Lasix study
Churchill moves remainder of meet to Ellis Park after HISA weighs in
FTC: Resumption of Anti-Doping and Medication Control Program now set for May 22
PA Racing Commission indicates AMDC Program won’t resume until May 22
←
older